Company intelligence / Profile preview

i-GETAID

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

i-GETAID is a biotechnology company focused on developing advanced diagnostic and therapeutic monitoring solutions. The company leverages a proprietary platform designed to enhance the detection and management of complex diseases, including cancer and infectious conditions. By integrating digital health tools with molecular insights, i-GETAID aims to provide clinicians with actionable data to improve patient outcomes. Their approach emphasizes precision medicine and the streamlining of diagnostic workflows through innovative technological integration.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Digital HealthDiagnostic
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on i-GETAID.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-GETAID.

Explore the full profile